Injectable Drug Delivery Resources

  1. Lyophilization vs. Liquid Formation: Why Lyo Offers Advantages 3/8/2022

    Lyophilization offers some alluring advantages in today’s complex market, but its challenges require innovation and expertise to surmount.

  2. Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products 10/16/2024

    Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.

  3. 'Smart Devices' vs. 'Smart Design' In User-Centric Autoinjector Design 2/18/2020

    Oval Medical has developed a novel Prefilled Primary Drug Container that resolves many drug compatibility and functionality issues associated with the use of traditional glass syringe and rubber plunger technologies.

  4. Nasal Vaccine Development, Manufacturing, And Device Selection 7/11/2023

    When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through small-scale clinical to commercial supply is crucial.

  5. Mitigating Particulate Risk In Injectables

    What are the sources of such particulates in injectables, and how should manufacturers apply the latest regulations to ensure best practice when producing sterile drug products?

  6. Microphysiological Systems: Closing The Gap Between Models And Medicine 9/2/2025

    Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.

  7. From Regulators To PUPSIT: Notes On Annex 1 Revision Implementation 5/26/2023

    Kevin Smyth, a biochemical engineer with 30 years of experience in the pharmaceutical industry, offers insights and expertise in working with firms to understand what regulators seek to meet new standards.

  8. Key Considerations For Selecting Flexible Fillers

    Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.

  9. Reducing Lead Time & Optimizing Costs 8/2/2022

    Explore how the use of this component platform produces significant savings, reduces elastomer SKU complexity, and increases speed to market.

  10. How To Find The Right Balance In Cell Therapy Manufacturing 5/20/2024

    The choice between closed and open fill/finish for cell therapy drug products ultimately involves a careful balance between safety, accessibility, efficacy, and the type of cell type used.